VALUE FOR PAYERS VS. PHYSICIANS: IS THERE CONVERGENCE BETWEEN VALUE ASSESSMENT BY ESMO, ASCO AND UK NICE DECISION?

被引：0
|
作者：
Rivolo, S. [1 ]
Ambavane, A. [1 ]
Rakonczai, P. [2 ]
Kapetanakis, V [1 ]
Benedict, A. [3 ]
机构：
[1] Evidera, London, England
[2] Evidera, Budapest, PE, Hungary
[3] Evidera Inc, Budapest, Hungary
来源：
VALUE IN HEALTH | 2019年 / 22卷
关键词：
D O I：
10.1016/j.jval.2019.04.347
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN225
引用
收藏
页码：S98 / S99
页数：2
相关论文
共 33 条
  • [1] ESMO-MCBS and health technology assessment (HTA): Does value for physicians correspond to value for payers?
    Ambavane, A.
    Benedict, A.
    Rivolo, S.
    Rakonczai, P.
    Kapetanakis, V.
    ANNALS OF ONCOLOGY, 2019, 30 : 671 - 671
  • [2] Comparison of value frameworks in oncology: how much do ESMO and ASCO ratings agree with early benefit assessment in Germany?
    Werner, S.
    Rasch, A.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 100 - 100
  • [3] ICER vs. IERC: Theoretical health economics vs. practical decision maker based value evidence
    Walt, J. G.
    VALUE IN HEALTH, 2007, 10 (03) : A192 - A192
  • [4] "NET HEALTH BENEFIT" - ASCO VS. ICER VALUE FRAMEWORKS: ARE WE TALKING ABOUT THE SAME THING?
    Ta, J.
    Devine, B.
    Garrison, L.
    VALUE IN HEALTH, 2019, 22 : S62 - S62
  • [5] ACCELERATING ACCESS TO MEDICAL TECHNOLOGIES: AN OVERVIEW OF THE NICE EARLY VALUE ASSESSMENT PILOT PROJECT IN THE UK
    So, D.
    Hearne, E.
    Stapleton, N.
    Chang-Douglass, S.
    VALUE IN HEALTH, 2023, 26 (12) : S355 - S355
  • [6] Arthroscopic vs. open Bankart reconstruction: a comparison using expected value decision analysis
    Kailes, SB
    Richmond, JC
    KNEE SURGERY SPORTS TRAUMATOLOGY ARTHROSCOPY, 2001, 9 (06) : 379 - 385
  • [7] Assessment of Value Using the American Society of Clinical Oncology (ASCO) and European Society of Medical Oncology (ESMO) Frameworks for Novel Therapies for the Hematologic Malignancies
    Cheung, Matthew C.
    Cheng, Sierra
    McDonald, Erica
    Arciero, Vanessa
    Qureshi, Mahin
    Chan, Kelvin
    BLOOD, 2016, 128 (22)
  • [8] Arthroscopic vs. open Bankart reconstruction: a comparison using expected value decision analysis
    Steven B. Kailes
    John C. Richmond
    Knee Surgery, Sports Traumatology, Arthroscopy, 2001, 9 : 379 - 385
  • [9] Choosing PD-1 Inhibitors in Oncology Setting, Left or Right?-Lessons From Value Assessment With ASCO-VF and ESMO-MCBS
    Jiang, Qian
    Feng, Mei
    Li, Youping
    Lang, Jinyi
    Wei, Hua
    Yu, Ting
    FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [10] THE DECISION TO ACQUIRE LISTED VS. UNLISTED FIRMS: DETERMINANTS AND VALUE EFFECTS IN THE SPANISH STOCK MARKET
    Farinos, Jose E.
    Herrero, Begona
    Latorre, Miguel A.
    REVISTA DE ECONOMIA APLICADA, 2017, 25 (73): : 55 - 94
1234